Mark Warner: “The second thing, which has been mentioned by my colleagues and certainly applies in the life sciences, is this idea of…”

“The second thing, which has been mentioned by my colleagues and certainly applies in the life sciences, is this idea of making sure the R&D tax credit is good, and stable, and that we are not playing a game of red light/green light with that tax credit.”